Berkeley and Broad fight for CRISPR rights before USPTO
The USPTO has heard what will likely be the last important patent interference proceeding to come before a panel of its judges. The proceedings are going out with a bang with a hearing over the celebrated CRISPR gene editing technology
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: